SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. – TTNP

Merger Details - Titan Pharmaceuticals Inc (Nasdaq: TTNP) is proposing a merger with BSKE Ltd, under which Titan shareholders are expected to own approximately 13.3% of the combined company [1] Law Firm Information - Monteverde & Associates PC is investigating the proposed merger between Titan Pharmaceuticals and BSKE Ltd [1] - The law firm has a track record of recovering money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report [1] - Monteverde & Associates PC is headquartered at the Empire State Building in New York City and has experience litigating in trial and appellate courts, including the U S Supreme Court [2] Contact Information - Shareholders of Titan Pharmaceuticals can contact Juan Monteverde, Esq via email at jmonteverde@monteverdelaw com or by telephone at (212) 971-1341 for additional information [3] - The law firm's address is The Empire State Building, 350 Fifth Ave Suite 4740, New York, NY 10118, United States of America [4]